Gujarat Magazine

Glioblastoma Clinical Trial Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Glioblastoma Clinical Trial Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Glioblastoma clinical trial analysis report delivers important insights into ongoing research on 200+ pipeline Glioblastoma drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10, 2026 –

Read Full Article

Glioma Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 180+ Leading Players Wheeling the Therapeutics Landscape

The Glioma clinical trial analysis report delivers important insights into ongoing research on 180+ pipeline Glioma drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 10, 2026- DelveInsight’s

Read Full Article

ANCA Vasculitis Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The ANCA Vasculitis clinical trial analysis report delivers important insights into ongoing research of 12+ pipeline ANCA Vasculitis drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10,

Read Full Article

The PH-ILD Therapeutics Market Size in the 7MM was valued at ~USD 3 billion in 2025 and is projected to expand at a CAGR of 3.9% by 2036

The PH-ILD clinical trial analysis report delivers important insights into ongoing research on multiple pipeline PH-ILD drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10, 2026- DelveInsight’s

Read Full Article

COPD Clinical Trial Pipeline Gains Momentum: 65+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Chronic Obstructive Pulmonary Disease clinical trial analysis report delivers important insights into ongoing research of 65+ pipeline Chronic Obstructive Pulmonary Disease drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

Read Full Article

Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2036 – DelveInsight | Regeneron, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception

The Key Eosinophilic Esophagitis Companies in the market include – Sanofi/Regeneron Pharmaceuticals, Dr. Falk Pharma GmbH, AstraZeneca and Amgen, Ellodi Pharmaceuticals, Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical,

Read Full Article

Atopic Dermatitis Market Set for Strong Expansion Through 2036 Amid Rising Investment Interest – DelveInsight | Kymab, BiomX, LEO Pharma, GSK, Arjil Pharma, SCM Lifescience, Sun Pharma, Brickell Bio

The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB

Read Full Article

Alzheimer’s Disease Market Trends, Innovation, and Future Growth Outlook to 2036 – DelveInsight | Alpha Cognition, Biogen, Eisai, Eli Lilly, Otsuka Pharma, Lundbeck, Suven Life Sciences, Roche

The Key Alzheimer’s Disease Companies in the market include – Alpha Cognition, Biogen/Eisai, Eli Lilly, Otsuka Pharma/ Lundbeck, Suven Life Sciences, Roche, Annovis Bio, and others . The Alzheimer’s Disease

Read Full Article

Multiple Sclerosis Market Outlook 2036: Growth Trends, Competitive Landscape, and Future Opportunities by 2034 – DelveInsight | Biogen, Immune Response BioPharma, ImCyse, Atara Bio, Emerald Health

The Key Multiple Sclerosis Companies in the market include – Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharmaceuticals,

Read Full Article

Non-Hodgkin Lymphoma Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma, Eli Lilly

(Las Vegas, Nevada, United States) – September 10, 2026: As per DelveInsight’s assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 180+ key

Read Full Article

Prostate Cancer Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Bayer, J&J, Astellas Pharma, Pfizer, Janssen R&D, Tesaro, Sanofi, MacroGenics

The Key Prostate Cancer Companies in the market include – Bayer, Johnson & Johnson Innovative Medicine (Janssen), Astellas Pharma, Pfizer,

Read Full Article

Multiple Myeloma Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | Regeneron, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb

The Key Multiple Myeloma Companies in the market include – Regeneron Pharmaceuticals, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb, Carsgen Therapeutics,

Read Full Article

Type 2 Diabetes Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast – DelveInsight | Eli Lilly, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences

The Key Type 2 Diabetes Companies in the market include – Eli Lilly and Company, Regor Pharmaceuticals Inc., AstraZeneca, Eccogene,

Read Full Article

EGFR-NSCLC Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | Dizal Pharma, Eli Lilly, Cullinan Oncology, Taiho Pharma, AstraZeneca, J&J Innova

The Key Epidermal growth factor receptor-Non Small Cell Lung Cancer Companies in the market include – AstraZeneca, J&J Innovative Medicine,

Read Full Article

Obesity Market to Witness Strong Growth and Significant Market Expansion by 2036 – DelveInsight | Rhythm Pharma, Boehringer Ingelheim, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical

The Key Obesity Companies in the market include – Rhythm Pharma, Boehringer Ingelhium, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical,

Read Full Article

Pertussis Market Size, Share, Growth, Epidemiology and Forecast to 2036

DelveInsight’s latest report, “Pertussis – Market Insight, Epidemiology and Market Forecast – 2036,” provides a comprehensive assessment of the global

Read Full Article

Triple Negative Breast Cancer Market to Reach Significant Growth by 2036, Driven by Advancements in Immunotherapy, Targeted Therapies, and Next-generation Treatment Approaches | DelveInsight

DelveInsight’s latest report, “Triple Negative Breast Cancer Market Insights, Epidemiology and Market Forecast – 2036,” provides a comprehensive analysis of

Read Full Article

Malignant Pleural Effusion Market to Grow at 4.9% CAGR Through 2036, Driven by Rising Cancer Burden, Increasing Demand for Minimally Invasive Treatments, and Emerging Therapeutic Approaches | DelveIns

DelveInsight’s latest report, “Malignant Pleural Effusion Market Insights, Epidemiology and Market Forecast – 2036,” provides a comprehensive analysis of the

Read Full Article

Shingles Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Shingles clinical trial analysis report delivers important insights into ongoing research of 20+ pipeline Shingles drugs, clinical strategies, upcoming

Read Full Article

Graft Versus Host Disease Clinical Trial Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Graft versus host disease (GVHD) clinical trial analysis report delivers important insights into ongoing research of 50+ pipeline GVHD

Read Full Article

Recent Posts

Glioblastoma Clinical Trial Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Read Full Article

Categories